SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Emanuele Durante-Mangoni, Domenico Iossa, Daniela Pinto, Rosa Molaro, Federica Agrusta, Cristiano Amarelli, Enrico Ragone, Maria Grimaldi, Ciro Maiello, Riccardo Utili, Adefovir treatment for chronic hepatitis B in heart transplant recipients, Clinical Transplantation, 2013, 27, 3
  2. 2
    Jessica P. Hwang, Anna S.-F. Lok, Management of patients with hepatitis B who require immunosuppressive therapy, Nature Reviews Gastroenterology & Hepatology, 2013, 11, 4, 209

    CrossRef

  3. 3
    Ramazan Idilman, Mutlu Arat, Evaluation and management of hepatitis B virus infection in hematopoietic stem cell transplantation: before and after transplantation, Expert Review of Anti-infective Therapy, 2011, 9, 8, 641

    CrossRef

  4. 4
    Filomena Morisco, Fabiana Castiglione, Antonio Rispo, Tommaso Stroffolini, Roberto Vitale, Stefano Sansone, Rocco Granata, Ambrogio Orlando, Riccardo Marmo, Gabriele Riegler, Maurizio Vecchi, Livia Biancone, Nicola Caporaso, Hepatitis B virus infection and immunosuppressive therapy in patients with inflammatory bowel disease, Digestive and Liver Disease, 2011, 43, S40

    CrossRef

  5. 5
    Hank S. Wang, Steven-Huy B. Han, Management of Hepatitis B in Special Patient Populations, Clinics in Liver Disease, 2010, 14, 3, 505

    CrossRef

  6. 6
    Jesús Sanz Sanz, Lucía Silva Fernández, José Luis Calleja Panero, Mónica Fernández-Castro, José Luis Andreu Sánchez, Infliximab en la espondilitis anquilosante asociada a infección crónica por el virus de la hepatitis B. Papel del tratamiento con lamivudina, Reumatología Clínica, 2008, 4, 4, 159

    CrossRef

  7. 7
    Jesús Sanz Sanz, Lucía Silva Fernández, José Luis Calleja Panero, Mónica Fernández-Castro, José Luis Andreu Sánchez, Infliximab in Ankylosing Spondylitis Associated With Chronic Hepatitis B Infection. Role of Lamivudine Therapy, Reumatología Clínica (English Edition), 2008, 4, 4, 159

    CrossRef

  8. 8
    S. Domm, J. Cinatl, U. Mrowietz, The impact of treatment with tumour necrosis factor-α antagonists on the course of chronic viral infections: a review of the literature, British Journal of Dermatology, 2008, 159, 6
  9. 9
    J. S. Lubel, A. G. Testro, P. W. Angus, Hepatitis B virus reactivation following immunosuppressive therapy: guidelines for prevention and management, Internal Medicine Journal, 2007, 37, 10
  10. 10
    Yi-Wen Huang, Chun-Jen Liu, Ming-Yang Lai, Po-Huang Lee, Meng-Kung Tsai, Shoei-Shen Wang, Ming-Kuen Lai, Jia-Horng Kao, Discontinuation of lamivudine treatment for hepatitis flare after kidney or heart transplantation in hepatitis B surface antigen-positive patients: A retrospective case series, Clinical Therapeutics, 2006, 28, 9, 1327

    CrossRef

  11. 11
    Ariella Bar-Gil Shitrit, Mordechai R. Kramer, Ilana Bakal, Gilles Morali, Ziv Ben Ari, David Shitrit, Lamivudine Prophylaxis for Hepatitis B Virus Infection After Lung Transplantation, The Annals of Thoracic Surgery, 2006, 81, 5, 1851

    CrossRef

  12. 12
    C.-J. Liu, J.-H. Kao, P.-J. Chen, T.-C. Chen, F.-Y. Lin, M.-Y. Lai, D.-S. Chen, Overlap lamivudine treatment in patients with chronic hepatitis B receiving adefovir for lamivudine-resistant viral mutants, Journal of Viral Hepatitis, 2006, 13, 6
  13. 13
    Feng-Chiao Tsai, Song-Chou Hsieh, Ding-Shinn Chen, Jin-Chuan Sheu, Ding-Shinn Chen, Reactivation of Hepatitis B Virus in Rheumatologic Patients Receiving Immunosuppressive Agents, Digestive Diseases and Sciences, 2006, 51, 9, 1627

    CrossRef

  14. 14
    K.-M. Chiu, T.-Y. Lin, S.-H. Chu, Successful Heterotopic Heart Transplant After Cardiopulmonary Bypass Rescue of an Arrested Donor Heart, Transplantation Proceedings, 2006, 38, 5, 1514

    CrossRef

  15. 15
    S.S. Wang, N.K. Chou, N.H. Chi, R.B. Hsu, S.C. Huang, Y.S. Chen, H.Y. Yu, C.I. Tsao, W.J. Ko, M.Y. Lai, S.H. Chu, Successful Treatment of Hepatitis B Virus Infection With Lamivudine After Heart Transplantation, Transplantation Proceedings, 2006, 38, 7, 2138

    CrossRef

  16. 16
    V. W.-S. Wong, H. L.-Y. Chan, M. L. Wong, J. S.-L. Tam, N. W.-Y. Leung, Clinical course after stopping lamivudine in chronic hepatitis B patients with lamivudine-resistant mutants, Alimentary Pharmacology & Therapeutics, 2004, 19, 3
  17. 17
    Tatsuo Kanda, Osamu Yokosuka, Fumio Imazeki, Setsuko Yoshida, Yutaka Suzuki, Keiichi Nagao, Hiromitsu Saisho, Corticosteroids and lamivudine combined to treat acute severe flare-up in a chronic hepatitis B and C patient, Journal of Gastroenterology and Hepatology, 2004, 19, 2
  18. 18
    S.-S. Wang, N.-K. Chou, W.-J. Ko, H.-Y. Yu, Y.-S. Chen, R.-B. Hsu, S.-C. Huang, N.-H. Chi, C.-I. Tsao, M.-Y. Lai, C.-S. Liau, Y.-T. Lee, Heart transplantation using donors positive for hepatitis, Transplantation Proceedings, 2004, 36, 8, 2371

    CrossRef

  19. 19
    YUN-FAN LIAW, NANCY LEUNG, RICHARD GUAN, GEORGE KK LAU, ISMAIL MERICAN, Asian-Pacific consensus statement on the management of chronic hepatitis B: An update, Journal of Gastroenterology and Hepatology, 2003, 18, 3
  20. 20
    Giuseppe Rossi, Prophylaxis with Lamivudine of Hepatitis B Virus Reactivation in Chronic HbsAg Carriers with Hemato-oncological Neoplasias Treated with Chemotherapy, Leukemia & Lymphoma, 2003, 44, 5, 759

    CrossRef

  21. 21
    Yun-Fan Liaw, Results of lamivudine trials in Asia, Journal of Hepatology, 2003, 39, 111

    CrossRef

  22. 22
    Edward Gane, Helen Pilmore, Management of chronic viral hepatitis before and after renal transplantation, Transplantation, 2002, 74, 4, 427

    CrossRef

  23. 23
    Nancy Leung, Hepatitis B surface antigen-positive organ transplantation recipients: Can lamivudine alter their fate?, Journal of Gastroenterology and Hepatology, 2001, 16, 9